Who
Stephen J. Sullivan
Director
Company insider
Files Form 4 as: Director, Interpace Biosciences; Corporate Sr. Vice President, Covance.
In numbers
- Trades disclosed
- 29
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $4.2M
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 3 Feb 2006
- Last trade
- 20 Aug 2026
- Last filed
- 20 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 20 Aug 2026filed 20 Aug 2026 | Interpace Biosciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —69,252 at $0.00 | filing |
| 20 Aug 2026filed 20 Aug 2026 | Interpace Biosciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —69,252 at $0.00 | filing |
| 9 Jul 2020filed 10 Jul 2020 | Interpace Biosciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —29,300 at $0.00 | filing |
| 7 Mar 2018filed 9 Mar 2018 | Interpace Biosciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —19,200 at $0.00 | filing |
| 7 Mar 2018filed 9 Mar 2018 | Interpace BiosciencesMedical Devices | SEC FORM 4 Code A | —4,800 | filing |
| 25 Sep 2017filed 26 Sep 2017 | Interpace Biosciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —13,000 at $0.00 | filing |
| 15 Mar 2017filed 17 Mar 2017 | Interpace Biosciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —13,000 at $0.00 | filing |
| 3 Feb 2016filed 5 Feb 2016 | Interpace BiosciencesMedical Devices | SEC FORM 4 Code A | $47K100,000 at $0.47 | filing |
| 3 Jun 2015filed 4 Jun 2015 | Interpace BiosciencesMedical Devices | SEC FORM 4 Code A | $45K34,091 at $1.32 | filing |
| 4 Jun 2014filed 5 Jun 2014 | Interpace BiosciencesMedical Devices | SEC FORM 4 Code A | $45K9,956 at $4.52 | filing |
| 4 Jun 2013filed 6 Jun 2013 | Interpace BiosciencesMedical Devices | SEC FORM 4 Code A | $45K10,068 at $4.47 | filing |
| 5 Jun 2012filed 7 Jun 2012 | Interpace BiosciencesMedical Devices | SEC FORM 4 Code A | $45K5,577 at $8.07 | filing |
| 31 May 2011filed 2 Jun 2011 | Interpace BiosciencesMedical Devices | SEC FORM 4 Code A | $45K6,522 at $6.90 | filing |
| 3 Jun 2010filed 7 Jun 2010 | Interpace BiosciencesMedical Devices | SEC FORM 4 Code A | $45K5,689 at $7.91 | filing |
| 4 Jun 2009filed 8 Jun 2009 | Interpace BiosciencesMedical Devices | SEC FORM 4 Code A | $45K12,262 at $3.67 | filing |
| 4 Jun 2008filed 6 Jun 2008 | Interpace Biosciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —5,555 at $0.00 | filing |
| 5 Jun 2007filed 7 Jun 2007 | Interpace BiosciencesMedical Devices | SEC FORM 4 Code A | $45K4,411 at $10.20 | filing |
| 6 Jun 2006filed 8 Jun 2006 | Interpace BiosciencesMedical Devices | SEC FORM 4 Code A | $45K3,247 at $13.86 | filing |
| 3 Feb 2006filed 6 Feb 2006 | Covanceoption or derivative | SEC FORM 4 Code M | —16,000 at $0.00 | filing |
| 3 Feb 2006filed 6 Feb 2006 | Covanceoption or derivative | SEC FORM 4 Code M | —21,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
Related people
Nobody else traded the same names lately.